包装
pkg of 2 × 10 mL
制造商/商品名称
Roche
pH值（酸碱度）
7.2-7.4 (20 °C)
应用
detection
储存温度
2-8°C
一般描述
TUNEL稀释缓冲液可与原位细胞死亡检测试剂盒一起使用。它可用于稀释特殊应用中TUNEL反应的末端脱氧核苷酸转移酶（TdT），还可标记DNA链断裂，从而在单细胞水平上检测和定量测定细胞和组织中的凋亡细胞死亡。
应用
TUNEL 稀释缓冲液已用于：
- 在制备TUNEL 关键商业检测用 TUNEL 反应混合物的过程中用于稀释末端脱氧核苷酸转移酶 dUTP 缺口末端标记 （TUNEL）酶 (TdT)
- 定量测定大鼠肾脏中的细胞凋亡
- 稀释末端脱氧核苷酸转移酶溶液，用于体外鉴定
- TUNEL 测定用少突细胞的 DNA 片段化
TUNEL稀释缓冲液已用于末端脱氧核苷酸转移酶dUTP缺口末端标记（TUNEL）测定。
制备说明
工作浓度：结合物的工作浓度取决于应用和底物。
以下浓度为参考浓度：
储存条件（工作溶液）：TdT稀释液应在临用前配制，不可储存。
使用前，将TUNEL反应混合物一直放在冰上。
以下浓度为参考浓度：
- ELISA：100 mU/ml
- Western blot：100 mU/ml
储存条件（工作溶液）：TdT稀释液应在临用前配制，不可储存。
使用前，将TUNEL反应混合物一直放在冰上。
其他说明
仅用于生命科学研究。不可用于诊断。
警示用语：
Danger
危险声明
危险分类
Aquatic Chronic 3 - Carc. 1B Inhalation
WGK
WGK 2
闪点(°F)
does not flash
闪点(°C)
does not flash
Preclinical characterization of abemaciclib in hormone receptor positive breast cancer.
Torres-Guzman R, et al.
Oncotarget, 8(41), 69493-69493 (2017)
Yoshiki Hayashi et al.
Proceedings of the National Academy of Sciences of the United States of America, 101(28), 10338-10342 (2004-07-09)
Nanos (Nos) is one of the evolutionarily conserved proteins known to direct germ-line development. In Drosophila, maternal Nos protein maintains transcriptional quiescence in the germ-line progenitors or pole cells to repress ectopic expression of somatic genes. Here we show that
Jiarui Han et al.
Drug design, development and therapy, 14, 3223-3234 (2020-08-28)
Inflammation-induced podocyte apoptosis plays an important role in kidney injury during diabetic nephropathy (DN). Hirudin (HIR), a natural compound extracted from leeches, can inhibit inflammation. However, whether HIR can protect the kidneys against inflammation during DN is unknown. In the
Anna Lm Smith et al.
Nature cancer, 1(10), 976-989 (2020-10-20)
Oxidative phosphorylation (OXPHOS) defects caused by somatic mitochondrial DNA (mtDNA) mutations increase with age in human colorectal epithelium and are prevalent in colorectal tumours, but whether they actively contribute to tumorigenesis remains unknown. Here we demonstrate that mtDNA mutations causing
Raquel Torres-Guzmán et al.
Oncotarget, 8(41), 69493-69507 (2017-10-21)
Abemaciclib is an ATP-competitive, reversible kinase inhibitor selective for CDK4 and CDK6 that has shown antitumor activity as a single agent in hormone receptor positive (HR+) metastatic breast cancer in clinical trials. Here, we examined the mechanistic effects of abemaciclib
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门